Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.41
+0.47 (1.43%)
At close: Mar 9, 2026, 4:00 PM EDT
32.76
-0.65 (-1.95%)
After-hours: Mar 9, 2026, 6:09 PM EDT

Immunocore Holdings Revenue

In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth. Immunocore Holdings had revenue of $104.48M in the quarter ending December 31, 2025, with 24.30% growth.

Revenue (ttm)
$400.02M
Revenue Growth
+28.95%
P/S Ratio
4.18
Revenue / Employee
$763,389
Employees
524
Market Cap
1.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-4.63M-11.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.12B
Harmony Biosciences Holdings 868.45M
Innoviva 411.33M
Vericel 276.26M
Agios Pharmaceuticals 54.03M
Nanobiotix 11.93M
Revenue Rankings

IMCR News

More News